Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma за авторством Caleb N. Seavey (15056489)

Предмети:

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma за авторством Caleb N. Seavey (15056489)

Предмети:

Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети:

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети:

Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy за авторством Zev A. Wainberg (15047031)

Предмети:

Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети:

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети:

Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети:

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models за авторством Elizabeth R. Tucker (15053624)

Предмети: